{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:12:29Z","timestamp":1760184749874,"version":"build-2065373602"},"reference-count":74,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.hoc.2009.07.006","type":"journal-article","created":{"date-parts":[[2009,10,13]],"date-time":"2009-10-13T05:16:06Z","timestamp":1255410966000},"page":"1011-1031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults"],"prefix":"10.1016","volume":"23","author":[{"given":"Stephen J.","family":"Forman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2009.07.006_bib1","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1182\/blood-2005-04-1623","article-title":"Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII\/ECOG E2993","volume":"106","author":"Rowe","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib2","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V85.8.2025.bloodjournal8582025","article-title":"A five\u2014drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811","volume":"85","author":"Larson","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1182\/blood.V71.1.123.123","article-title":"Prognostic factors in a multicenter study for treatment of acute lymhoblastic leukemia in adults","volume":"71","author":"Hoelzer","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib4","first-page":"774","article-title":"Detection of minimal residual disease in childhood leukemia with the polymerase reaction","volume":"324","author":"Rovera","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2009.07.006_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199808273390904","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"339","author":"Cave","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2009.07.006_bib6","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1200\/JCO.2002.20.4.1094","article-title":"Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia","volume":"20","author":"Mortuza","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2009.07.006_bib7","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1182\/blood-2005-07-2708","article-title":"Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia","volume":"107","author":"Bruggemann","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib8","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1200\/JCO.2004.10.050","article-title":"Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial","volume":"22","author":"Thomas","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2009.07.006_bib9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11912-006-0068-7","article-title":"Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII\/ECOG E2993","volume":"8","author":"Rowe","year":"2006","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.hoc.2009.07.006_bib10","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood.V86.4.1619.bloodjournal8641619","volume":"86","author":"Attal","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib11","first-page":"453","article-title":"Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation: multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival","volume":"7","author":"Doney","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.hoc.2009.07.006_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00007890-198703000-00014","article-title":"Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission","volume":"43","author":"Blume","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.hoc.2009.07.006_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1200\/JCO.1988.6.2.227","article-title":"Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission","volume":"6","author":"Vernant","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2009.07.006_bib14","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood.V78.8.1923.1923","article-title":"Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission","volume":"78","author":"Chao","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib15","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1200\/JCO.1994.12.12.2580","article-title":"Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study","volume":"12","author":"Sebban","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2009.07.006_bib16","first-page":"383","article-title":"Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission","volume":"14","author":"Vey","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.hoc.2009.07.006_bib17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0301-472X(03)00231-5","article-title":"Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: a 15-year experience","volume":"31","author":"Jamieson","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.hoc.2009.07.006_bib18","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","volume":"111","author":"Goldstone","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1083-8791(00)70024-3","article-title":"Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"6","author":"Snyder","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.hoc.2009.07.006_bib20","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1182\/blood-2002-03-0704","article-title":"Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia \u2013 results of the prospective multicenter LALA-94 trial","volume":"100","author":"Dombret","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib21","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1182\/blood-2008-03-143115","article-title":"Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen","volume":"112","author":"Laport","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib22","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1182\/blood-2004-09-3785","article-title":"The effect of first-line imatinib therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"105","author":"Lee","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib23","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1182\/blood.V89.7.2602","article-title":"Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation","volume":"89","author":"Radich","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib24","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2006-04-019836","article-title":"Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia","volume":"109","author":"Carpenter","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib25","first-page":"73","article-title":"High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid leukemia and lymphoblastic leukemia","volume":"14","author":"Hiddemann","year":"1987","journal-title":"Semin Oncol"},{"key":"10.1016\/j.hoc.2009.07.006_bib26","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1158\/1078-0432.CCR-06-0606","article-title":"Approval summary: Nelarabine for the treatment of T-cell lymphoblastic leukemia\/lymphoma","volume":"12","author":"Cohen","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hoc.2009.07.006_bib27","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s00277-005-1090-9","article-title":"FLAG-IDA in the treatment of refractory\/relapsed adult acute lymphoblastic leukemia","volume":"84","author":"Specchia","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.hoc.2009.07.006_bib28","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1038\/sj.leu.2404824","article-title":"Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial","volume":"21","author":"Tavernier","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2009.07.006_bib29","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","article-title":"Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study","volume":"109","author":"Fielding","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib30","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1083-8791(03)00149-6","article-title":"Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia","volume":"9","author":"Doney","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.hoc.2009.07.006_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bmt.1705889","article-title":"Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review","volume":"41","author":"Bachanova","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.hoc.2009.07.006_bib32","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V97.6.1572","article-title":"Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome","volume":"97","author":"Cornelissen","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bmt.1705734","article-title":"Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor","volume":"40","author":"Chim","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.hoc.2009.07.006_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/sj.bmt.1705221","article-title":"Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation","volume":"37","author":"Dahlke","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.hoc.2009.07.006_bib35","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1200\/JCO.2004.07.130","article-title":"Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission","volume":"22","author":"Kiehl","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2009.07.006_bib36","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib37","first-page":"S15","article-title":"Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL)","volume":"11","author":"Appelbaum","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2009.07.006_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bmt.1701064","article-title":"Graft-versus-leukemia effects in T\u00a0lineage and B lineage acute lymphoblastic leukemia","volume":"21","author":"Passweg","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.hoc.2009.07.006_bib39","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.bmt.1703951","article-title":"A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society","volume":"31","author":"Esp\u00e9rou","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.hoc.2009.07.006_bib40","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbmt.2007.06.001","article-title":"Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease","volume":"13","author":"Lee","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.hoc.2009.07.006_bib41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/35077251","article-title":"Hematopoietic cell transplantation as immunotherapy","volume":"411","author":"Appelbaum","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.hoc.2009.07.006_bib42","first-page":"4374","article-title":"Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens","volume":"94","author":"Mutis","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib43","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1182\/blood.V91.6.2197","article-title":"Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution","volume":"91","author":"Warren","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib44","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/CJI.0b013e318052e1f4","article-title":"Manufacturing of large numbers of patient-specific T cells for adoptive immunotherapy: an approach to improving product safety, composition, and production capacity","volume":"30","author":"Tran","year":"2007","journal-title":"J Immunother"},{"key":"10.1016\/j.hoc.2009.07.006_bib45","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1172\/JCI32103","article-title":"Adoptive transfer of effector CD +8 T\u00a0cells derived from central memory cells establishes persistent T cell memory in primates","volume":"118","author":"Berger","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hoc.2009.07.006_bib46","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/blood-2002-07-1989","article-title":"T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect","volume":"101","author":"Cooper","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib47","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1600-0609.2004.00360.x","article-title":"Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies","volume":"74","author":"Valcarcel","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.hoc.2009.07.006_bib48","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/sj.leu.2402712","article-title":"Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease","volume":"16","author":"Arnold","year":"2002","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.hoc.2009.07.006_bib49","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.bmt.1705769","article-title":"Non-myeloablative stem cell transplantation in patients with relapsed acute lymphoblastic leukemia: results of a multicenter study","volume":"40","author":"Gutierrez-Aguirre","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.hoc.2009.07.006_bib50","unstructured":"Stein A, O'Donnell M, Snyder D, et\u00a0al. Reduced-intensity stem cell transplantation for high-risk acute lymphoblastic leukemia, Submitted for publication."},{"key":"10.1016\/j.hoc.2009.07.006_bib51","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3324\/haematol.11960","article-title":"Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation","volume":"93","author":"Mohty","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.hoc.2009.07.006_bib52","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood.V71.4.888.888","article-title":"High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission","volume":"71","author":"Coccia","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib53","first-page":"190","article-title":"High-dose cytarabine in consolidation chemotherapy or with bone marrow transplantation for patients with acute leukemia: preliminary results","volume":"12","author":"Champlin","year":"1985","journal-title":"Semin Oncol"},{"key":"10.1016\/j.hoc.2009.07.006_bib54","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJM198312013092202","article-title":"Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide","volume":"309","author":"Santos","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2009.07.006_bib55","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V70.5.1382.1382","article-title":"Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen","volume":"70","author":"Tutschka","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib56","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1200\/JCO.2000.18.2.340","article-title":"Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia","volume":"18","author":"Davies","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2009.07.006_bib57","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bbmt.2007.03.003","article-title":"Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation and thymoglobulin","volume":"13","author":"Russell","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.hoc.2009.07.006_bib58","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1182\/blood.V69.4.1015.1015","article-title":"Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies","volume":"69","author":"Blume","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib59","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood.V81.8.2187.2187","article-title":"A prospective randomized comparison of total body irradiation-etoposide versus busulfan cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a South-West Oncology Group study","volume":"81","author":"Blume","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib60","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bbmt.2005.12.029","article-title":"A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission","volume":"12","author":"Marks","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.hoc.2009.07.006_bib61","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood.V94.4.1237","article-title":"Phase I study of 131I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome","volume":"94","author":"Matthews","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib62","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbmt.2005.10.026","article-title":"Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation","volume":"12","author":"Wong","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.hoc.2009.07.006_bib63","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","article-title":"Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation","volume":"15","author":"Collins","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2009.07.006_bib64","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia","volume":"86","author":"Kolb","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib65","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/sj.leu.2402770","article-title":"Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)","volume":"16","author":"Wassman","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2009.07.006_bib66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/stemcells.20-1-3","article-title":"Autologous stem cell transplantation in acute lymphocytic leukemia","volume":"20","author":"Gorin","year":"2002","journal-title":"Stem Cells"},{"key":"10.1016\/j.hoc.2009.07.006_bib67","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.1993.11.10.1990","article-title":"Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy","volume":"11","author":"Fiere","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2009.07.006_bib68","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.seminhematol.2007.08.004","article-title":"Post-remission treatment for adult patients with acute lymphoblastic leukemia in first remission: is there a role for autologous stem cell transplantation?","volume":"44","author":"Willemze","year":"2007","journal-title":"Seminar Hematol"},{"issue":"7","key":"10.1016\/j.hoc.2009.07.006_bib69","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/sj.bmt.1705952","article-title":"Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research","volume":"41","author":"Bishop","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.hoc.2009.07.006_bib70","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1200\/JCO.2002.12.049","article-title":"Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia","volume":"20","author":"Ringd\u00e9n","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2009.07.006_bib71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.bmt.1703778","article-title":"Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow","volume":"31","author":"Garderet","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.hoc.2009.07.006_bib72","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1365-2141.2002.03650.x","article-title":"A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukaemia in complete remission","volume":"118","author":"Ooi","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2009.07.006_bib73","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1182\/blood-2008-10-184093","article-title":"Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation","volume":"113","author":"Bachanova","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.07.006_bib74","series-title":"Thomas' hematopoietic cell transplantation","first-page":"791","article-title":"Hematopoietic cell transplantation for acute lymphoblastic leukemia in adults","author":"Forman","year":"2008"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858809001415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858809001415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:53:44Z","timestamp":1760183624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858809001415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0889858809001415"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2009.07.006","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2009.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}